Singapore Medical Group (SMG)

UOBKH ups Singapore Medical Group's TP on 'attractive' valuation - THE EDGE SINGAPORE

Broker's Calls

UOBKH ups Singapore Medical Group's TP on 'attractive' valuation

UOB Kay Hian (UOBKH) is maintaining its “buy” call on private specialist and healthcare services provider Singapore Medical Group (SMG), but at a higher target price of 46 cents. 

Singapore Medical Group reports 49.5% lower earnings of $3.5 mil for 1H20

Results

Singapore Medical Group reports 49.5% lower earnings of $3.5 mil for 1H20

Singapore Medical Group (SMG) posted 49.5% lower earnings of $3.5 million for 1H20 ended June, from the $6.8 million registered a year ago due to the “challenging market conditions”, and lower numb

Broker's Calls

KGI starts Singapore Medical Group at 'outperform' on diverse network of specialist healthcare services

SINGAPORE (July 8): KGI Securities has initiated coverage on Singapore Medical Group (SMG) with an “outperform” call and target price of 34 cents, which represents a total upside of 39.0%, includin

Broker's Calls

Singapore Medical Group kept on 'neutral' as uncertainties loom

SINGAPORE (May 27): RHB Group Research is keeping “neutral” on Singapore Medical Group (SMG) but with a lowered target price of 25 cents from 35 cents previously, as uncertainties are still present

Company in the news

Companies hope for rosy outlook with injection of new aesthetic business

SINGAPORE (Oct 17): People say money cannot buy self-esteem, but it sure can buy a whole new look.

Results

Singapore Medical Group posts 3.5% growth in 2Q earnings to $3.5 mil on higher revenue

SINGAPORE (Aug 7): Singapore Medical Group saw its earnings rise 3.5% to $3.5 million for the 2Q19 ended June, from $3.4 million a year ago.

Broker's Calls

SMG upgraded to 'buy on dips' by RHB as CHAS raises stake

SINGAPORE (June 7): RHB Research is upgrading Singapore Medical Group (SMG) to “buy” from “neutral” previously, with an unchanged target price of 48 cents.

Broker's Calls

Singapore Medical Group kept at 'buy' on strong FY18 results, CHAS investment

SINGAPORE (Feb 21): RHB Research is maintaining Singapore Medical Group (SMG) at “buy” on news that shareholder CHA Healthcare Singapore (CHAS) is raising its stake in the group.

SMG calls for trading halt pending announcement as share price climbs 4.4%

SINGAPORE (Feb 20): Singapore Medical Group (SMG) at noon on Wednesday called for a trading halt “pending [the] release of [an] announcement”.

Be informed of the stories that matter

×